{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:01:27Z","timestamp":1791226887787,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007837","name":"Universit\u00e4t Bremen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The microRNA-371a-3p (M371) is a sensitive novel serum biomarker of testicular germ cell tumours (GCTs) and a certified test is available for consistent clinical testing. In view of the well-known biological analogies of GCTs and embryogenesis, we hypothesized that the marker substance M371 is also present in serum of pregnant women. The goal of this report was to analyse maternal serum for M371.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>M371 serum levels were measured in 36 third-trimester pregnant women. Control groups consisted of 12 non-pregnant young women, 12 healthy young males, and 12 patients with GCTs. M371 levels were measured by quantitative real time PCR using the certified M371 test with the standard cutoff of RQ\u2009=\u20095. Statistical methods involved receiver operating characteristics (ROC) analysis with Youden index analysis, and statistical comparisons of median serum levels of patients with those of controls as well as for comparisons of subgroups of patients according to age and infant sex.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>All pregnant women had measurable M371 levels, with 83.3% of the patients having elevated levels above the cutoff, while traces below cutoff were detected in the remainder. Healthy female and male controls were both below cutoff. ROC analysis revealed a 100% sensitivity and 100% specificity of the test when the cutoff of RQ\u2009=\u20090.4 defined by Youden index analysis was employed. The median level in pregnant women was significantly lower than that in GCT patients (10.8 [interquartile range 6.1\u201320.3] versus RQ\u2009=\u2009139.5 [IQR 54.9\u2013630.3], <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Individual M371 levels were not associated with patient age and with infant sex.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The evidence for elevated levels of microRNA-371a-p in maternal serum is a novel finding. This result accords with the various analogies between GCTs and embryogenesis documented previously. The finding supports the view that cells involved in human reproduction share epigenetic features with human embryonic stem cells. Further studies are required to explore if this finding could be utilized clinically.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40001-025-02906-8","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T03:42:07Z","timestamp":1754106127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expression of the novel serum biomarker of testicular germ cell tumours miR-371a-3p in serum of pregnant women: a case\u2013control study"],"prefix":"10.1186","volume":"30","author":[{"given":"K. P.","family":"Dieckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ragosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Klemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Belge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"2906_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0178-9","author":"JW Oosterhuis","year":"2019","unstructured":"Oosterhuis JW, Looijenga LHJ. Human germ cell tumours from a developmental perspective. Nat Rev Cancer. 2019. https:\/\/doi.org\/10.1038\/s41568-019-0178-9.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2906_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/BF00705305","volume":"408","author":"Jacobsen G Krag","year":"1986","unstructured":"Krag Jacobsen G. Histogenetic considerations concerning germ cell tumours. Morphological and immunohistochemical comparative investigation of the human embryo and testicular germ cell tumours. Virchows-Arch-A. 1986;408(5):509\u201325.","journal-title":"Virchows-Arch-A"},{"issue":"6","key":"2906_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0090-4295(1083)90320-90325","volume":"22","author":"JEJ Fowler","year":"1983","unstructured":"Fowler JEJ, Sesterhenn I, Stutzman RE, Mostofi FK. Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer. Urology. 1983;22(6):649\u201354. https:\/\/doi.org\/10.1016\/0090-4295(1083)90320-90325.","journal-title":"Urology"},{"issue":"6","key":"2906_CR4","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S0022-5347(17)58275-0","volume":"118","author":"PT Scardino","year":"1977","unstructured":"Scardino PT, Cox HD, Waldmann TA, Mcintire KR, Mittemeyer B, Javadpour N. The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis. J Urol. 1977;118(6):994\u20139.","journal-title":"J Urol"},{"issue":"7","key":"2906_CR5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/BF01754362","volume":"11","author":"B Zondek","year":"1932","unstructured":"Zondek B. Maligne Hodentumoren und Hypophysenvorderlappenhormone. Hormonale Diagnostik aus Harn, Hydrocelenfl\u00fcssigkeit und Tumorgewebe. Klin Wochenschr. 1932;11(7):274\u20139.","journal-title":"Klin Wochenschr"},{"issue":"4","key":"2906_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41585-41020-40296-x","volume":"17","author":"K Almstrup","year":"2020","unstructured":"Almstrup K, Lobo J, Morup N, Belge G, Rajpert-DeMeyts E, Looijenga LHJ, Dieckmann KP. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours. Nat Rev Urol. 2020;17(4):201\u201313. https:\/\/doi.org\/10.1038\/s41585-41020-40296-x.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"2906_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/bju.15288","volume":"128","author":"A Bagrodia","year":"2021","unstructured":"Bagrodia A, Savelyeva A, Lafin JT, Speir RW, Chesnut GT, Frazier AL, Woldu SL, Margulis V, Murray MJ, Amatruda JF, et al. Impact of circulating miRNA-371a-3p test on appropriateness of treatment and cost outcomes in patients with stage I nonseminomatous germ cell tumors. BJU Int. 2021;128(1):57\u201364.","journal-title":"BJU Int"},{"issue":"2","key":"2906_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ydbio.2004.02.019","volume":"270","author":"MR Suh","year":"2004","unstructured":"Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, Lee JY, Cha KY, Chung HM, Yoon HS, Moon SY, et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol. 2004;270(2):488\u201398.","journal-title":"Dev Biol"},{"issue":"6","key":"2906_CR9","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1634\/stemcells.2007-1081","volume":"26","author":"LC Laurent","year":"2008","unstructured":"Laurent LC, Chen J, Ulitsky I, Mueller FJ, Lu C, Shamir R, Fan JB, Loring JF. Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells Dev. 2008;26(6):1506\u201316.","journal-title":"Stem Cells Dev"},{"issue":"2\u20134","key":"2906_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1387\/ijdb.130020re","volume":"57","author":"R Eini","year":"2013","unstructured":"Eini R, Dorssers LC, Looijenga LH. Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer. Int J Dev Biol. 2013;57(2\u20134):319\u20133132.","journal-title":"Int J Dev Biol"},{"issue":"16","key":"2906_CR11","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1200\/JCO.18.01480","volume":"37","author":"KP Dieckmann","year":"2019","unstructured":"Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, et al. Serum levels of microRNA-371a-3p (M371 Test) as a new biomarker of testicular germ cell-tumors: results of a prospective multicentric study. J Clin Oncol. 2019;37(16):1412\u201323.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2906_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"3","key":"2906_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/15592294.15592021.11899887","volume":"17","author":"CG Howe","year":"2022","unstructured":"Howe CG, Foley HB, Kennedy EM, Eckel SP, Chavez TA, Faham D, Grubbs BH, Al-Marayati L, Lerner D, Suglia S, et al. Extracellular vesicle microRNA in early versus late pregnancy with birth outcomes in the MADRES study. Epigenetics. 2022;17(3):269\u201385. https:\/\/doi.org\/10.1080\/15592294.15592021.11899887.","journal-title":"Epigenetics"},{"issue":"9","key":"2906_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1080\/15592294.15592017.11358345","volume":"12","author":"RS Rodosthenous","year":"2017","unstructured":"Rodosthenous RS, Burris HH, Sanders AP, Just AC, Dereix AE, Svensson K, Solano M, T\u00e9llez-Rojo MM, Wright RO, Baccarelli AA. Second trimester extracellular microRNAs in maternal blood and fetal growth: an exploratory study. Epigenetics. 2017;12(9):804\u201310. https:\/\/doi.org\/10.1080\/15592294.15592017.11358345.","journal-title":"Epigenetics"},{"issue":"1","key":"2906_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12958-12021-00883-12951","volume":"20","author":"C L\u00e9gar\u00e9","year":"2022","unstructured":"L\u00e9gar\u00e9 C, Cl\u00e9ment AA, Desgagn\u00e9 V, Thibeault K, White F, Guay SP, Arsenault BJ, Scott MS, Jacques P\u00c9, Perron P, et al. Human plasma pregnancy-associated miRNAs and their temporal variation within the first trimester of pregnancy. Reprod Biol Endocrinol. 2022;20(1):14. https:\/\/doi.org\/10.1186\/s12958-12021-00883-12951.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"2906_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jri.2012.11.001","volume":"97","author":"DM Morales-Prieto","year":"2013","unstructured":"Morales-Prieto DM, Ospina-Prieto S, Chaiwangyen W, Schoenleben M, Markert UR. Pregnancy-associated miRNA-clusters. J Reprod Immunol. 2013;97(1):51\u201361.","journal-title":"J Reprod Immunol"},{"key":"2906_CR17","doi-asserted-by":"publisher","first-page":"R259","DOI":"10.1530\/REP-17-0603","volume":"155","author":"H Hayder","year":"2018","unstructured":"Hayder H, O\u2019Brien J, Nadeem U, Peng C. MicroRNAs: crucial regulators of placental development. Reproduction. 2018;155:R259\u201371.","journal-title":"Reproduction"},{"issue":"4 Suppl","key":"2906_CR18","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1016\/j.ajog.2015.1005.1057","volume":"213","author":"JF Mouillet","year":"2015","unstructured":"Mouillet JF, Ouyang Y, Coyne CB, Sadovsky Y. MicroRNAs in placental health and disease. Am J Obstet Gynecol. 2015;213(4 Suppl):S163-172. https:\/\/doi.org\/10.1016\/j.ajog.2015.1005.1057.","journal-title":"Am J Obstet Gynecol"},{"key":"2906_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.placenta.2020.1007.1001","volume":"102","author":"DM Morales-Prieto","year":"2020","unstructured":"Morales-Prieto DM, Favaro RR, Markert UR. Placental miRNAs in feto-maternal communication mediated by extracellular vesicles. Placenta. 2020;102:27\u201333. https:\/\/doi.org\/10.1016\/j.placenta.2020.1007.1001.","journal-title":"Placenta"},{"issue":"9","key":"2906_CR20","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3390\/cells11091588","volume":"11","author":"M \u017darkovi\u0107","year":"2022","unstructured":"\u017darkovi\u0107 M, Hufsky F, Markert UR, Marz M. The role of non-coding RNAs in the human placenta. Cells. 2022;11(9):1588. https:\/\/doi.org\/10.3390\/cells11091588.","journal-title":"Cells"},{"issue":"1","key":"2906_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00709-020-01548-3","volume":"258","author":"A Gottlieb","year":"2021","unstructured":"Gottlieb A, Flor I, Nimzyk R, Burchardt L, Helmke B, Langenbuch M, Spiekermann M, Feidicker S, Bullerdiek J. The expression of miRNA encoded by C19MC and miR-371-3 strongly varies among individual placentas but does not differ between spontaneous and induced abortions. Protoplasma. 2021;258(1):209\u201318.","journal-title":"Protoplasma"},{"issue":"8","key":"2906_CR22","doi-asserted-by":"publisher","first-page":"E836","DOI":"10.1152\/ajpendo.00660.02012","volume":"304","author":"Y Gu","year":"2013","unstructured":"Gu Y, Sun J, Groome LJ, Wang Y. Differential miRNA expression profiles between the first and third trimester human placentas. Am J Physiol Endocrinol Metab. 2013;304(8):E836-843. https:\/\/doi.org\/10.1152\/ajpendo.00660.02012.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2906_CR23","doi-asserted-by":"publisher","first-page":"58037","DOI":"10.18632\/oncotarget.10867","volume":"8","author":"T van Agthoven","year":"2017","unstructured":"van Agthoven T, Looijenga LH. Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test). Oncotarget. 2017;8:58037\u201349.","journal-title":"Oncotarget"},{"issue":"3","key":"2906_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.euf.2022.1004.1008","volume":"8","author":"CD Fankhauser","year":"2022","unstructured":"Fankhauser CD, Nu\u00f1o MM, Murray MJ, Frazier L, Bagrodia A. Circulating microRNAs for detection of germ cell tumours: a narrative review. Eur Urol Focus. 2022;8(3):660\u20132. https:\/\/doi.org\/10.1016\/j.euf.2022.1004.1008.","journal-title":"Eur Urol Focus"},{"issue":"11","key":"2906_CR25","doi-asserted-by":"publisher","first-page":"e78487","DOI":"10.71371\/journal.pone.0078487","volume":"8","author":"CL Whitehead","year":"2013","unstructured":"Whitehead CL, Teh WT, Walker SP, Leung C, Larmour L, Tong S. Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero. PLoS ONE. 2013;8(11):e78487. https:\/\/doi.org\/10.71371\/journal.pone.0078487.","journal-title":"PLoS ONE"},{"key":"2906_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.semcancer.2014.1007.1003","volume":"29","author":"MA Rijlaarsdam","year":"2014","unstructured":"Rijlaarsdam MA, Looijenga LH. An oncofetal and developmental perspective on testicular germ cell cancer. Semin Cancer Biol. 2014;29:59\u201374. https:\/\/doi.org\/10.1016\/j.semcancer.2014.1007.1003.","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"2906_CR27","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/1097-0142(19860501)57:9<1842::AID-CNCR2820570924>3.0.CO;2-I","volume":"57","author":"GD Braunstein","year":"1986","unstructured":"Braunstein GD, Thompson R, Princler GL, McIntire KR. Trophoblastic proteins as tumor markers in nonseminomatous germ cell tumors. Cancer. 1986;57(9):1842\u20135.","journal-title":"Cancer"},{"key":"2906_CR28","doi-asserted-by":"publisher","first-page":"113964","DOI":"10.1016\/j.biopha.2022.113964","volume":"156","author":"S Kannampuzha","year":"2022","unstructured":"Kannampuzha S, Ravichandran M, Mukherjee AG, Wanjari UR, Renu K, Vellingiri B, Iyer M, Dey A, George A, Gopalakrishnan AV. The mechanism of action of non-coding RNAs in placental disorders. Biomed Pharmacother. 2022;156:113964.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"2906_CR29","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s10815-10024-03268-10816","volume":"41","author":"C Tang","year":"2024","unstructured":"Tang C, Hu W. Biomarkers and diagnostic significance of non-coding RNAs in extracellular vesicles of pathologic pregnancy. J Assist Reprod Genet. 2024;41(10):2569\u201384. https:\/\/doi.org\/10.1007\/s10815-10024-03268-10816.","journal-title":"J Assist Reprod Genet"},{"issue":"8","key":"2906_CR30","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1586\/14737159.14732015.11053468","volume":"15","author":"A Lycoudi","year":"2015","unstructured":"Lycoudi A, Mavreli D, Mavrou A, Papantoniou N, Kolialexi A. miRNAs in pregnancy-related complications. Expert Rev Mol Diagn. 2015;15(8):999\u20131010. https:\/\/doi.org\/10.1586\/14737159.14732015.11053468.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"2906_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00438-00025-02244-00438","volume":"300","author":"H Pan","year":"2025","unstructured":"Pan H, Ouyang B, Zhang H, Zhao C. Non-coding RNAs: the architects of placental development and pregnancy success. Mol Genet Genomics. 2025;300(1):39. https:\/\/doi.org\/10.1007\/s00438-00025-02244-00438.","journal-title":"Mol Genet Genomics"},{"issue":"4","key":"2906_CR32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/andr.12595","volume":"7","author":"WPA Boellaard","year":"2019","unstructured":"Boellaard WPA, Gillis AJM, van Leenders GJLH, Stoop H, van Agthoven T, Dorssers LCJ, Dinkelman-Smit M, Boormans JL, Looijenga LHJ. Cellular origin of microRNA-371a-3p in healthy males based on systematic urogenital tract tissue evaluation. Andrology. 2019;7(4):463\u20138.","journal-title":"Andrology"},{"key":"2906_CR33","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.18632\/oncotarget.27565","volume":"11","author":"G Belge","year":"2020","unstructured":"Belge G, Hennig F, Dumlupinar C, Grobelny F, Junker K, Radtke A, Dieckmann KP. Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor. Oncotarget. 2020;11:1462\u201373.","journal-title":"Oncotarget"},{"key":"2906_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/andr.12664","volume":"7","author":"A Radtke","year":"2019","unstructured":"Radtke A, Dieckmann K-P, Grobelny F, Salzbrunn A, Oing C, Schulze W, Belge G. Expression of miRNA-371a-3p in seminal plasma and ejaculate is associated with sperm concentration. Andrology. 2019;7:469\u201374.","journal-title":"Andrology"},{"key":"2906_CR35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s12020-016-1150-z","volume":"57","author":"M Pelloni","year":"2016","unstructured":"Pelloni M, Coltrinari G, Paoli D, Pallotti F, Lombardo F, Lenzi A, Gandini L. Differential expression of miRNAs in the seminal plasma and serum of testicular cancer patients. Endocrine. 2016;57:518\u201327.","journal-title":"Endocrine"},{"issue":"1","key":"2906_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ncrna.2023.1011.1006","volume":"9","author":"L Wang","year":"2023","unstructured":"Wang L, Shi L, Zhou B, Hong L, Gong H, Wu D. METTL3-mediated lncRNA HOXD-AS1 stability regulates inflammation, and the migration and invasion of trophoblast cells via the miR-135a\/ \u03b2-TRCP axis. Noncoding RNA Res. 2023;9(1):12\u201323. https:\/\/doi.org\/10.1016\/j.ncrna.2023.1011.1006.","journal-title":"Noncoding RNA Res"},{"issue":"4","key":"2906_CR37","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ncrna.2024.1006.1007","volume":"9","author":"MA Senousy","year":"2024","unstructured":"Senousy MA, Shaker OG, Elmaasrawy AHZ, Ashour AM, Alsufyani SE, Arab HH, Ayeldeen G. Serum lncRNAs TUG1, H19, and NEAT1 and their target miR-29b\/SLC3A1 axis as possible biomarkers of preeclampsia: potential clinical insights. Noncoding RNA Res. 2024;9(4):995\u20131008. https:\/\/doi.org\/10.1016\/j.ncrna.2024.1006.1007.","journal-title":"Noncoding RNA Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02906-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02906-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02906-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:35:47Z","timestamp":1757331347000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02906-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2906"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02906-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients gave written informed consent. This study was approved by the Ethics Committee of the Chamber of Physicians in Bremen (HR\/RE-301A). All study activities were conducted in accordance with the Declaration of Helsinki of the World Medical Association, amended by the 64th General Assembly in October 2013.\"","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"Klaus-Peter Dieckmann and Gazanfer Belge possess 5.7% ownership shares of mir|detect Company, Bremerhaven, Germany. Markus Klemke is employee of miRdetect Company, Bremerhaven, Germany. All other authors declare they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"697"}}